Press Release | Tue Sep 10, 2013 1:01am EDT

Macitentan (Opsumit) morbidity and mortality data in pulmonary arterial hypertension from SERAPHIN study presented at European Respiratory Society Congress 2013.

* Reuters is not responsible for the content in this press release.